101538-7
SMA residual risk [Interpretation] in Blood by Molecular genetics method Narrative
Active
Term Description
This test is based on sequencing and targeted analysis of specific variants . The testing depends largely upon the individual's ethnic background. A negative result may indicate a reduced carrier risk for some or all diseases being tested, this risk cannot be eliminated.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- SMA residual risk
- Property
- Imp
- Time
- Pt
- System
- Bld
- Scale
- Nar
- Method
- Molgen
Additional Names
- Short Name
- SMA residual risk Bld-Imp
- Display Name
- SMA residual risk Molgen Nar (Bld) [Interp]
- Consumer Name Alpha Get Info
- Interpretation of SMA residual risk test result, Blood
Basic Attributes
- Class
- MOLPATH.MUT
- Type
- Laboratory
- First Released
- Version 2.74
- Last Updated
- Version 2.75
- Order vs. Observation
- Both
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Riesgo residual SMA: |
fr-FR | French (France) | SMA risque résiduel: |
it-IT | Italian (Italy) | SMA, rischio residuo: Synonyms: Genetica molecolare Impressione/interpretazione di studio Mutazione genica Patologia molecolare Punto nel tempo (episodio) Rischio residuo di SMA Sangue |
zh-CN | Chinese (China) | SMA 残余风险: Synonyms: SMA(脊髓性肌萎缩、 |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=101538-7
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright